Revealing Engagement Patterns Among Hepatic Encephalopathy Patients
Not yet recruiting
- Conditions
- Hepatic Encephalopathy
- Registration Number
- NCT06201988
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
This study aims to investigate the influences behind patient choices regarding involvement, discontinuation, or re-engagement in hepatic encephalopathy clinical trials. Uncovering these factors is essential to enhance the relevance and efficacy of future research endeavors.
In essence, this trial aims to deepen understanding of the factors influencing participation in hepatic encephalopathy clinical trials. Elevating participation rates could expedite the development of innovative treatments for this challenging condition.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Signed Written Informed Consent
- Aged ≥ 18 years old
- No prior treatment for hepatic encephalopathy
Exclusion Criteria
- Participant is actively receiving study therapy in another
- Inability to provide written informed consent
- Women of childbearing potential without a negative pregnancy test; or women who are lactating.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of patients who decide to join in a hepatic encephalopathy clinical trial 3 months Number of hepatic encephalopathy patients who remain in clinical trial until completion 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States